{"product_id":"gmre-vrio-analysis","title":"Global Medical REIT Inc. (GMRE): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eIs Global Medical REIT Inc. (GMRE) truly built to last? This VRIO analysis cuts straight to the core, rigorously testing whether its Value, Rarity, Inimitability, and Organization combine to forge an unshakeable competitive advantage. Dive in now to uncover the definitive verdict on its market strength and what it means for its future success.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: Triple-Net Lease Portfolio Structure\n\u003c\/h2\u003e\n\u003cp\u003eYou’re looking at Global Medical REIT Inc.'s core asset strategy, and honestly, the triple-net lease structure is the engine room. It’s what makes the revenue stream look so dependable on paper.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e The triple-net lease model is designed to deliver highly predictable, low-management rental revenue because tenants shoulder most of the operating expenses - think property taxes, insurance, and maintenance. This structure is key to the reported \u003cstrong\u003e$118.4 million\u003c\/strong\u003e in Annualized Base Rent (ABR) as of September 30, 2025, across 191 buildings.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e While triple-net leases are standard in the healthcare REIT world, GMRE's specific blend of medical office buildings (MOBs) and specialized facilities like rehab centers offers a degree of differentiation. Competitors have similar assets, but the exact portfolio mix isn't a dime a dozen.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e I’d peg this as medium imitability. Any well-capitalized competitor can buy a similar medical property tomorrow. But, replicating the exact, long-term lease agreements, especially those secured through deep industry relationships, takes time and deal flow. It's not something you can copy overnight.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Organization here is high because the entire Global Medical REIT Inc. business model is engineered around sourcing, underwriting, and managing these specific, net-lease structures. Their reported 95.2% leased occupancy rate as of September 30, 2025, shows they are effectively running the system.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Right now, it’s a temporary advantage. It’s a solid, proven foundation, but in real estate, a strong lease structure alone rarely guarantees a sustained competitive edge against well-funded peers. You need something more proprietary.\u003c\/p\u003e\n\n\u003cp\u003eHere’s a quick look at the portfolio underpinning this analysis as of September 30, 2025:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Buildings\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e191\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Annualized Base Rent (ABR)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$118.4 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeased Occupancy\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Lease Term (WALT)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.3 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Rent Escalations\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.1%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Debt Outstanding\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$710 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe weighted average rent escalations of \u003cstrong\u003e2.1%\u003c\/strong\u003e are important; they provide a modest inflation hedge, which is better than nothing, but not spectacular in this environment. Also, remember the recent CEO change and the dividend cut in 2025 - that signals management is prioritizing balance sheet flexibility over immediate shareholder payouts, which impacts how you view their organizational execution.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eQ3 2025 Adjusted FFO per share\/unit was \u003cstrong\u003e$1.12\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe portfolio is geographically spread across 35 states.\u003c\/li\u003e\n\u003cli\u003eDebt is 70% fixed-rate, which helps manage interest rate risk.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFinance: draft a sensitivity analysis on WALT rollover risk for the next 36 months by next Tuesday.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: High Occupancy and Tenant Quality\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e The \u003cstrong\u003e95.2%\u003c\/strong\u003e leased occupancy as of September 30, 2025, ensures high current cash flow from 5.2 million square feet. The portfolio generated \u003cstrong\u003e$118.4 million\u003c\/strong\u003e in Annualized Base Rent (ABR) as of that date.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e High. Maintaining near-full occupancy while navigating market shifts is tough; \u003cstrong\u003e90%\u003c\/strong\u003e of tenants are health systems. The portfolio consists of \u003cstrong\u003e191\u003c\/strong\u003e buildings leased to \u003cstrong\u003e315\u003c\/strong\u003e tenants.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e High. Tenant relationships and property location quality are hard to copy quickly.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e High. Management’s focus on creditworthy tenants supports this stability. The REIT reported a weighted-average cost of all borrowing at \u003cstrong\u003e3.96%\u003c\/strong\u003e during Q3 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained. Quality tenants in essential healthcare real estate offer durable cash flow.\u003c\/p\u003e\n\u003cp\u003eKey Portfolio and Financial Statistics as of September 30, 2025:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003cth\u003eContext\/Period\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeased Occupancy\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeasable Square Feet\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePortfolio Size\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnnualized Base Rent (ABR)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$118.4 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted-Average Lease Term (WALT)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.3 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePortfolio Duration\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted-Average Rent Escalations\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.1%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eContractual Escalations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 2025 Adjusted Funds From Operations (AFFO)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$16.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eQuarterly Performance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYear-over-Year Same-Store Cash NOI Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.7%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eThird Quarter 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Buildings Owned\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e191\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePortfolio Scale\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eOperational Highlights Supporting Stability:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eFunds From Operations (FFO) for Q3 2025 was \u003cstrong\u003e$14.5 million\u003c\/strong\u003e, or \u003cstrong\u003e$1.00 per share and unit\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eAFFO for Q3 2025 increased \u003cstrong\u003e4%\u003c\/strong\u003e year-over-year on a per share and unit basis.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eThe Company successfully re-leased a facility previously occupied by Steward Health Care to an affiliate of Christus Health through a \u003cstrong\u003e15-year\u003c\/strong\u003e triple-net lease.\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003cli\u003eTotal consolidated debt outstanding as of September 30, 2025, was \u003cstrong\u003e$710 million\u003c\/strong\u003e, with a leverage ratio of \u003cstrong\u003e47.3%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: Strategic Acquisition Execution\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eStrategic Acquisition Execution\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eValue: Ability to deploy capital accretively, like the recent $69.6 million five-property portfolio acquisition at a strong 9.0% cap rate. The total YTD acquisition spend through Q3 2025 was $69.6 million at a weighted average cap rate of 8.7%.\u003c\/p\u003e\n\u003cp\u003eRarity: Medium. Many REITs struggle to find deals at that yield in the current environment. The 9.0% cap rate on the portfolio is attractive compared to the YTD weighted average of 8.7% on all acquisitions.\u003c\/p\u003e\n\u003cp\u003eImitability: Medium. Competitors can match the price, but not the deal sourcing network, which the former CEO cited as key to winning the 9.0% cap rate portfolio.\u003c\/p\u003e\n\u003cp\u003eOrganization: High. The new CEO, Mark Decker, Jr., is expected to continue this disciplined, opportunistic approach. Mr. Decker was appointed in June 2025, succeeding Jeffrey Busch.\u003c\/p\u003e\n\u003cp\u003eCompetitive Advantage: Temporary. Execution speed is key; others will catch up if the pipeline dries up.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSupporting Data on Acquisition Execution and Leadership Transition\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003eContext\/Date\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eFive-Property Portfolio Purchase Price\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$69.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnounced October 2024, completed by April 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFive-Property Portfolio Cap Rate\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e9.0%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnounced October 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFive-Property Portfolio Annualized Base Rent\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$6.3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTotal for the portfolio\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eYTD (through Q3 2025) Acquisition Spend\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$69.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eWeighted Average Cap Rate of \u003cstrong\u003e8.7%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio Leased Occupancy\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio Leased Square Feet\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of June 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Lease Term\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.3 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eCEO Mark Decker, Jr. Background and Alignment\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAppointed CEO effective immediately in June 2025.\u003c\/li\u003e\n\u003cli\u003eBrings 'deep capital markets expertise' and experience leading a transition at Centerspace (NYSE: CSR) to a 'focused owner-operator of apartments, resulting in higher earnings quality, balance sheet simplicity and an award-winning performance-oriented culture.'\u003c\/li\u003e\n\u003cli\u003ePrior role included founding and co-leading the net lease real estate investment strategy at Proterra Investment Partners.\u003c\/li\u003e\n\u003cli\u003eCEO purchased 10,000 shares of GMRE stock valued at \u003cstrong\u003e$325,100\u003c\/strong\u003e on December 8, 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical Medical REIT Inc. (GMRE) - VRIO Analysis: Debt Structuring and Interest Rate Hedging\n\u003c\/h2\u003e\n\n\u003cp\u003e\nThe analysis below is based on financial data as of September 30, 2025, and the credit facility amendment effective October 8, 2025.\n\u003c\/p\u003e\n\n\u003ch3\u003eValue\u003c\/h3\u003e\n\u003cp\u003e\nThe fixed-rate debt structure provides a direct hedge against rising short-term interest rates. As of September 30, 2025, 70% of Total Gross Debt, amounting to $712,853 thousand, was fixed-rate. The Fixed Charge Coverage Ratio for the quarter was 2.62x.\n\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eDebt Statistic\u003c\/th\u003e\n\u003cth\u003eAs of September 30, 2025\u003c\/th\u003e\n\u003cth\u003ePro-Forma As of October 8, 2025 (1)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Gross Debt (in thousands)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$712,853\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$712,853\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFixed Rate Debt-to-Total Debt\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e70%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e70%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Interest Rate\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e4.06%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e3.96%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Maturity\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1.3 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e4.4 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eRarity\u003c\/h3\u003e\n\u003cp\u003e\nThe 70% fixed-rate debt positioning is relatively rare among peers who may carry higher floating-rate exposure, providing insulation from immediate rate hikes. The weighted average maturity was extended from 1.3 years to 4.4 years through the October 2025 amendment.\n\u003c\/p\u003e\n\n\u003ch3\u003eImitability\u003c\/h3\u003e\n\u003cp\u003e\nThe successful execution of $350 million in forward starting interest rate swaps to hedge the new Term Loan A tranches, establishing effective interest rates between 4.75% and 4.84%, required specific market timing and balance sheet foresight. The existing $350 million Term Loan A swaps provided an all-in fixed rate of 2.85% through April 2026.\n\u003c\/p\u003e\n\n\u003ch3\u003eOrganization\u003c\/h3\u003e\n\u003cp\u003e\nThe finance team demonstrated active management by amending and restating the credit facility to optimize the maturity profile. The organization executed on extending the revolver maturity to October 2029 (with options to October 2030) and restructuring Term Loan A.\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eExisting $350 million Term Loan A swaps remain in place until April 2026 at an all-in fixed rate of 2.85%.\u003c\/li\u003e\n\u003cli\u003eNew Term Loan A tranches ($100 million A-1, $100 million A-2, $150 million A-3) are hedged with forward swaps, resulting in effective rates from 4.75% to 4.84%.\u003c\/li\u003e\n\u003cli\u003eTerm Loan B of $150,000 thousand remains fixed at 4.05% (pro-forma) maturing in February 2028.\u003c\/li\u003e\n\u003cli\u003eThe Revolver component of $211,700 thousand is floating (SOFR + 1.50% pro-forma) with a maturity extended to October 2030.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch3\u003eCompetitive Advantage\u003c\/h3\u003e\n\u003cp\u003e\nThe proactive debt restructuring and hedging strategy create a sustained advantage by buffering the company against unexpected macro interest rate shocks. The weighted average cost of all borrowing decreased from 4.06% to 3.96% pro-forma following the October 2025 facility amendment.\n\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: Alignment with Outpatient Care Trends\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Portfolio composition benefits directly from the projected \u003cstrong\u003e21% to 22%\u003c\/strong\u003e growth in ambulatory surgery and home health services through 2034. GMRE’s focus on net-lease outpatient medical properties capitalizes on the structural shift in healthcare delivery.\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eGMRE Portfolio Data (Latest)\u003c\/th\u003e\n\u003cth\u003eMarket Growth Trend (Outpatient\/ASC)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio Leasable SF\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e5.2 million\u003c\/strong\u003e (As of September 30, 2025)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio Occupancy\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e95.2%\u003c\/strong\u003e (As of September 30, 2025)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio WALT\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e5.3 years\u003c\/strong\u003e (As of September 30, 2025)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eU.S. Ambulatory Surgery Center (ASC) Market Value\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eUSD 99.26 billion\u003c\/strong\u003e (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProjected U.S. ASC Market Value by 2034\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eUSD 173.55 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eU.S. ASC Market CAGR (2025 to 2034)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.75%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProjected Surgical Procedure Growth at ASCs (10 Years)\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003ctd\u003eAt least \u003cstrong\u003e25%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecent Acquisition Cap Rate\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e9.0%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Medium. While many REITs pivot, GMRE’s existing asset base is already well-aligned. GMRE targets properties operated by profitable healthcare systems or physician groups at the forefront of care delivery.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Medium. It’s easier to buy existing outpatient centers than to convert older assets. GMRE focuses on acquiring properties with rents below market rates, specifically targeting rents about \u003cstrong\u003e30%\u003c\/strong\u003e below market rates for organic growth potential upon lease reset.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e High. Acquisition criteria explicitly favor these growing sub-sectors. The strategy is to capitalize on the trend toward decentralized outpatient care through high-yield investments.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAcquisitions favor tenants specializing in procedural-based areas such as cardiology, gastroenterology, imaging, and oncology.\u003c\/li\u003e\n\u003cli\u003eRecent acquisitions, such as a five-property portfolio, were secured at a cap rate of \u003cstrong\u003e9.0%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe company maintains a target leverage ratio below \u003cstrong\u003e40%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained. This structural tailwind supports long-term rent growth and asset value appreciation.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePortfolio Annualized Base Rent (ABR) was \u003cstrong\u003e$118.4 million\u003c\/strong\u003e as of September 30, 2025.\u003c\/li\u003e\n\u003cli\u003eWeighted average annual rent escalations are \u003cstrong\u003e2.1%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eConsolidated debt outstanding was \u003cstrong\u003e$710 million\u003c\/strong\u003e as of September 30, 2025, representing \u003cstrong\u003e47.3%\u003c\/strong\u003e leverage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: Capital Recycling Program\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eCapital Recycling Program\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eValue: Selling non-core or mature assets, like the five dispositions generating aggregate gross proceeds of \u003cstrong\u003e$13.4 million\u003c\/strong\u003e in the first nine months of 2025, frees up capital.\u003c\/p\u003e\n\u003cp\u003eRarity: Low. Most REITs engage in asset sales, but the discipline to sell is what matters.\u003c\/p\u003e\n\u003cp\u003eImitability: Low. It requires constant market assessment to know what to sell and when.\u003c\/p\u003e\n\u003cp\u003eOrganization: High. Management uses proceeds to fund higher-yielding acquisitions or deleverage.\u003c\/p\u003e\n\u003cp\u003eCompetitive Advantage: Temporary. It’s a necessary operational function, not a unique barrier to entry.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDisposition Activity Summary\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003ePeriod\u003c\/th\u003e\n\u003cth\u003eNumber of Dispositions\u003c\/th\u003e\n\u003cth\u003eAggregate Gross Proceeds\u003c\/th\u003e\n\u003cth\u003eAggregate Gain\/(Loss)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNine Months Ended September 30, 2025\u003c\/td\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$13.4 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$1.9 million\u003c\/strong\u003e Gain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThird Quarter 2025\u003c\/td\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$3.8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$0.3 million\u003c\/strong\u003e Gain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFull Year 2024\u003c\/td\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$60.7 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$4.2 million\u003c\/strong\u003e Gain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNine Months Ended September 30, 2024\u003c\/td\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$20.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e($1.6 million)\u003c\/strong\u003e Loss\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThird Quarter 2024\u003c\/td\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$12.1 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$1.8 million\u003c\/strong\u003e Gain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSecond Quarter 2024 (July 2024 Sale)\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$11.0 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e$1.7 million\u003c\/strong\u003e Gain\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSecond Quarter 2024 (June 2024 Sale)\u003c\/td\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$8.1 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e($3.4 million)\u003c\/strong\u003e Loss\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eManagement utilizes proceeds from dispositions to fund accretive investment activity.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRelated Acquisition Activity\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eAcquisition Event\u003c\/th\u003e\n\u003cth\u003eAggregate Purchase Price\u003c\/th\u003e\n\u003cth\u003eStatus\/Timing\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e15-Property Portfolio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$80.3 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCompleted in 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFive-Property Portfolio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$69.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003ePurchase agreement entered; expected close H1 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTranche 1 of 15-Property Portfolio (5 properties)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$30.8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCompleted July 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRemaining 10 Properties of 15-Property Portfolio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$49.5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eExpected to close in the first half of 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003ePortfolio metrics relevant to asset quality and recycling effectiveness:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePortfolio leased occupancy was \u003cstrong\u003e96.4%\u003c\/strong\u003e as of December 31, 2024.\u003c\/li\u003e\n\u003cli\u003ePortfolio leased occupancy was \u003cstrong\u003e95.2%\u003c\/strong\u003e as of September 30, 2025.\u003c\/li\u003e\n\u003cli\u003eAnnualized Base Rent (ABR) as of December 31, 2024: \u003cstrong\u003e$110 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eABR as of September 30, 2025 (for acquired 5-property portfolio at purchase): \u003cstrong\u003e$6.3 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: Joint Venture Growth Platform\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eJoint Venture Growth Platform\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eValue: The joint venture with Heitman allows for surgical acquisitions of core-plus assets off-balance-sheet, preserving dry powder.\u003c\/p\u003e\n\u003cp\u003eRarity: High. This specific partnership structure for targeted medical asset acquisition is not widely replicated.\u003c\/p\u003e\n\u003cp\u003eImitability: High. The terms and relationship with a major capital partner like Heitman are unique.\u003c\/p\u003e\n\u003cp\u003eOrganization: High. It shows management’s ability to structure complex, risk-sharing growth vehicles.\u003c\/p\u003e\n\u003cp\u003eCompetitive Advantage: Sustained. Access to external, non-recourse capital for growth is a powerful differentiator.\u003c\/p\u003e\n\u003cp\u003eThe formation of the Joint Venture (JV) with Heitman in December 2024 provides a quantifiable platform for growth, as evidenced by the initial transaction details:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eJV Partner\u003c\/td\u003e\n\u003ctd\u003eHeitman Capital Management LLC\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHeitman Assets Under Management (AUM)\u003c\/td\u003e\n\u003ctd\u003eOver \u003cstrong\u003e$48 billion\u003c\/strong\u003e (as of 12\/31\/2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGMRE Investment Percentage\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e12.5%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHeitman Investment Percentage\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e87.5%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross Proceeds to GMRE from Seed Portfolio Sale\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$35.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGMRE Initial Capital Investment (from Proceeds)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$2.1 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSeed Portfolio Mortgage Principal Amount\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$17.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNumber of Seed Assets\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e2\u003c\/strong\u003e properties\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe JV is intended to be a vehicle for future acquisitions, leveraging GMRE's sourcing and asset management platform alongside Heitman's capital base.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eThe Seed Portfolio consisted of two medical outpatient buildings (MOBs) totaling approximately \u003cstrong\u003e115,604 square feet\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eOne seed asset, the Cornerstone Westchester MOB in High Point, NC (\u003cstrong\u003e97,811 square feet\u003c\/strong\u003e), was recapitalized for slightly more than \u003cstrong\u003e$28 million\u003c\/strong\u003e, equating to \u003cstrong\u003e$286 per square foot (PSF)\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe other seed asset, the TDDC MOB in Fort Worth, TX (\u003cstrong\u003e18,084 square feet\u003c\/strong\u003e), was recapped for about \u003cstrong\u003e$7.2 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAs of December 31, 2024, GMRE's total portfolio comprised \u003cstrong\u003e4.8 million\u003c\/strong\u003e leasable square feet with annualized base rent of \u003cstrong\u003e$110 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFor the full year 2024, GMRE completed acquisitions totaling \u003cstrong\u003e$80.3 million\u003c\/strong\u003e for a 15-property portfolio at an \u003cstrong\u003e8.0%\u003c\/strong\u003e cap rate.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: Lease Escalation Structure\n\u003c\/h2\u003e\n\u003cp\u003e\n\u003ch\u003eValue\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003eThe portfolio features weighted average annual rent escalations of \u003cstrong\u003e2.1%\u003c\/strong\u003e, providing built-in revenue growth independent of new acquisitions. This escalation rate is supported by the existing portfolio composition.\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAs of September 30, 2025, the weighted average annual rent escalations were \u003cstrong\u003e2.1%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAs of December 31, 2024, the weighted average annual rent escalations were \u003cstrong\u003e2.2%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\n\u003c\/p\u003e\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (As of September 30, 2025)\u003c\/th\u003e\n\u003cth\u003eValue (As of December 31, 2024)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Annual Rent Escalations\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.1%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Lease Term (WALT)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.3 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.6 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio Leasable Square Feet\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e4.8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnnualized Base Rent (ABR)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$118.4 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$110 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePortfolio Occupancy\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e96.4%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNumber of Buildings\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e191\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e190\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\n\u003ch\u003eRarity\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003eLow. Rent escalators are standard in most net leases.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003ch\u003eImitability\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003eLow. Competitors can write similar clauses into new leases.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003ch\u003eOrganization\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003eMedium. The existing portfolio locks in this growth, but new deals must maintain it. The organization must consistently execute on acquisitions and lease renewals to sustain the current escalation profile.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003ch\u003eCompetitive Advantage\u003c\/h\u003e\n\u003c\/p\u003e\n\u003cp\u003eTemporary. It’s a feature of the contract, not a unique organizational skill.\n\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eGlobal Medical REIT Inc. (GMRE) - VRIO Analysis: Weighted Average Lease Term (WALT)\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eWeighted Average Lease Term (WALT)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eValue: A WALT of \u003cstrong\u003e5.3 years\u003c\/strong\u003e as of September 30, 2025, offers a reasonable balance between near-term cash flow visibility and future leasing upside.\u003c\/p\u003e\n\u003cp\u003eRarity: Medium. It’s not the longest, but it’s solid for a portfolio undergoing optimization.\u003c\/p\u003e\n\u003cp\u003eImitability: Medium. Competitors can target similar lease durations.\u003c\/p\u003e\n\u003cp\u003eOrganization: Medium. Management balances long-term stability with the need to reset rents in a rising environment.\u003c\/p\u003e\n\u003cp\u003eCompetitive Advantage: Temporary. It’s a function of the current lease schedule, which shortens every year.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePortfolio Metrics as of September 30, 2025:\u003c\/strong\u003e\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Lease Term (WALT)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.3 years\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeighted Average Annual Rent Escalations\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.1%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeased Occupancy\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e95.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLeasable Square Feet\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5.2 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnnualized Base Rent\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$118.4 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003cstrong\u003eQ3 2025 Financial and Operational Highlights:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRental revenue for the third quarter increased by \u003cstrong\u003e8.4%\u003c\/strong\u003e year-over-year to \u003cstrong\u003e$37.0 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eFunds from Operations (FFO) was \u003cstrong\u003e$14.5 million\u003c\/strong\u003e, or \u003cstrong\u003e$1.00 per share and unit\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAdjusted Funds from Operations (AFFO) was \u003cstrong\u003e$16.2 million\u003c\/strong\u003e, or \u003cstrong\u003e$1.12 per share and unit\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eNet loss attributable to common stockholders was \u003cstrong\u003e$6.0 million\u003c\/strong\u003e, or \u003cstrong\u003e$0.45 per diluted share\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe net loss was primarily due to a \u003cstrong\u003e$6.3 million\u003c\/strong\u003e impairment charge related to an unoccupied facility sold during the quarter.\u003c\/li\u003e\n\u003cli\u003eInterest expense for the quarter was \u003cstrong\u003e$8.2 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe Company established a \u003cstrong\u003e$50 million\u003c\/strong\u003e common stock repurchase program in August 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCapital Allocation Directive:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDraft the Q4 2025 capital allocation plan focusing on the Heitman JV by Friday.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516173934741,"sku":"gmre-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/gmre-vrio-analysis.png?v=1740178043","url":"https:\/\/dcf-model.com\/fr\/products\/gmre-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}